By Professor Emad El-Omar

Journal articles

Ando T; Tsuzuki T; Mizuno T; Minami M; Ina K; Kusugami K; Takamatsu J; Adachi K; El-Omar E; Ohta M; Goto H, 2004, 'Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura', Helicobacter, 9, pp. 443 - 452, http://dx.doi.org/10.1111/j.1083-4389.2004.00261.x

El-Omar EM, 2004, 'The role of interleukin-1 beta in Helicobacter pylori-associated disease', Netherlands Journal of Medicine, 62, pp. 47 - 52

De Sanjose S; Dickie A; Alvaro T; Romagosa V; Garcia Villanueva M; Domingo-Domenech E; Fernandez De Sevilla A; El-Omar E, 2004, 'Helicobacter pylori and malignant lymphoma in Spain', Cancer Epidemiology Biomarkers and Prevention, 13, pp. 944 - 948, http://dx.doi.org/10.1158/1055-9965.944.13.6

Zambon CF; Basso D; Navaglia F; Falda A; Belluco C; Fogar P; Greco E; Gallo N; Farinati F; Cardin R; Rugge M; Di Mario F; Plebani M; El-Omar EM; Rabkin CS; Chow WH, 2004, 'Increased Risk of Noncardia Gastric Cancer Associated with Proinflammatory Cytokine Gene Polymorphisms [11] (multiple letters)', Gastroenterology, 126, pp. 382 - 383, http://dx.doi.org/10.1053/j.gastro.2003.08.042

Macarthur M; Hold GL; El-Omar EM, 2004, 'Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy', American Journal of Physiology Gastrointestinal and Liver Physiology, 286, pp. G515 - G520, http://dx.doi.org/10.1152/ajpgi.00475.2003

Furuta T; Shirai N; Xiao F; El-Omar EM; Rabkin CS; Sugimura H; Ishizaki T; Ohashi K, 2004, 'Polymorphism of interleukin-1β affects the eradication rates of Helicobacter pylori by triple therapy', Clinical Gastroenterology and Hepatology, 2, pp. 22 - 30, http://dx.doi.org/10.1016/S1542-3565(03)00288-X

El-Omar EM; Rabkin CS; Chow WH, 2004, 'Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms - Reply', GASTROENTEROLOGY, 126, pp. 383 - 384, http://dx.doi.org/10.1053/j.gastro.2003.11.033

El-Omar EM, 2004, 'The role of interleukin-I beta in Helicobacter pylori-associated disease', NETHERLANDS JOURNAL OF MEDICINE, 62, pp. 47 - 52

El-Omar EM; Rabkin CS; Gammon MD; Vaughan TL; Risch HA; Schoenberg JB; Stanford JL; Mayne ST; Goedert J; Blot WJ; Fraumeni JF; Wong-Ho C, 2003, 'Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms', Gastroenterology, 124, pp. 1193 - 1201, http://dx.doi.org/10.1016/S0016-5085(03)00157-4

Garza-González E; Hold G; Pérez-Pérez GI; Bosques-Padilla FJ; Tijerina-Menchaca R; Maldonado-Garza HJ; el-Omar E, 2003, 'Role of polymorphism of certain cytokines in gastric cancer in Mexico. Preliminary results', Revista De Gastroenterologia De Mexico, 68, pp. 107 - 112

Troost E; Hold GL; Smith MG; Chow WH; Rabkin CS; McColl KEL; El-Omar EM, 2003, 'The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk.', Canadian Journal of Gastroenterology Journal Canadien De Gastroenterologie, 17 Suppl B, http://dx.doi.org/10.1155/2003/397060

McColl KEL; El-Omar E; Pharoah P; Caldas C; Huntsman D, 2002, 'E-cadherin germline mutations and risk of gastric cancer [1] (multiple letters)', Gastroenterology, 123, pp. 1406 - 1407, http://dx.doi.org/10.1053/gast.2002.36382

Hisada M; Gold B; Kim N; Owens M; Cranston B; El-Omar E; Hanchard B, 2002, 'Risk factors of Helicobacter pylori infection in the Jamaica mother-infant cohort study', AMERICAN JOURNAL OF EPIDEMIOLOGY, 155, pp. s105 - s105, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000175955500411&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Takata T; El-Omar E; Camorlinga M; Thompson SA; Minohara Y; Ernst PB; Blaser MJ, 2002, 'Helicobacter priori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ mice', Infection and Immunity, 70, pp. 3073 - 3079, http://dx.doi.org/10.1128/IAI.70.6.3073-3079.2002

Furuta T; Elomar EM; Xiao F; Shirai N; Takashima M; Sugimurra H, 2002, 'Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan', Gastroenterology, 123, pp. 92 - 105, http://dx.doi.org/10.1053/gast.2002.34156

Furuta T; El-Omar EM; Xiao F; Shirai N; Takashima M; Sugimura H, 2002, 'Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. (vol 123, pg 92, 2002)', GASTROENTEROLOGY, 123, pp. 957 - 957

El-Omar EM; Malfertheiner P, 2001, 'Helicobacter pylori infection and gastric cancer', Current Opinion in Gastroenterology, 17, pp. S24 - S27

El-Omar EM; Carrington M; Chow WH; McColl KEL; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer', Nature, 412, pp. 99, http://dx.doi.org/10.1038/35083631

El-Omar EM; Carrington M; Chow WH; McColl KE; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.', Nature, 412, pp. 99

El-Omar EM, 2001, 'The importance of interleukin 1 β in Helicobacter pylori associated disease', Gut, 48, pp. 743 - 747, http://dx.doi.org/10.1136/gut.48.6.743

McColl KEL; Murray LS; Gillen D; Dickson A; Fletcher J; Henry E; Kelman A; El-Omar E; Hilditch T, 2001, 'Non-invasive HP testing versus endoscopy with HP testing for dyspepsia', GUT, 48, pp. A14 - A15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167334700053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

El-Omar EM, 2001, 'Cytokine gene polymorphisms and risk of gastric cancer', Japanese Journal of Gastroenterology, 98, pp. A303 - A305, http://dx.doi.org/10.11405/nisshoshi1964.98.87sokai_A303

El-Omar EM; Chow WH; Rabkin CS, 2001, 'Gastric cancer and H. pylori: Host genetics open the way', Gastroenterology, 121, pp. 1002 - 1004, http://dx.doi.org/10.1053/gast.2001.28739

El-Omar EM; You W-C; Chow W-H; Fraumeni JF; Rabkin CS, 2001, 'IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China', Gastroenterology, 120, pp. A743 - A743, http://dx.doi.org/10.1016/s0016-5085(08)83701-8

McColl KEL; Murray LS; Gillen D; Dickson A; Fletcher J; Henry E; Kelman AW; El-Omar EM; Hilditch TE, 2001, 'Non-invasive H-pylori testing versus endoscopy with H-pylori testing for dyspepsia', GASTROENTEROLOGY, 120, pp. A238 - A238

El-Omar EM; Chow W-H; Gammon MD; Vaughan TL; Risch HA; Fraumeni JF, 2001, 'Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas', Gastroenterology, 120, pp. A86 - A86, http://dx.doi.org/10.1016/s0016-5085(08)80425-8

El-Omar E; McColl KEL, 2000, 'When enthusiasm is infectious - Reply', GASTROENTEROLOGY, 119, pp. 276 - 276, http://dx.doi.org/10.1016/S0016-5085(00)70071-0

El-Omar EM; Carrington M; Chow WH; McColl KEL; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2000, 'Interleukin-1 polymorphisms associated with increased risk of gastric cancer', Nature, 404, pp. 398 - 402, http://dx.doi.org/10.1038/35006081

McColl KEL; El-Omar E; Gillen D, 2000, 'Helicobacter pylori gastritis and gastric physiology', Gastroenterology Clinics of North America, 29, pp. 687 - 703, http://dx.doi.org/10.1016/S0889-8553(05)70138-2

ElOmar EM; Oien K; Murray LS; ElNujumi A; Wirz A; Gillen D; Williams C; Fullarton G; McColl KEL, 2000, 'Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori', Gastroenterology, 118, pp. 22 - 30, http://dx.doi.org/10.1016/S0016-5085(00)70410-0

McColl KEL; Dickson A; El-Nujumi A; El-Omar E; Kelman A, 2000, 'Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease', American Journal of Gastroenterology, 95, pp. 101 - 105, http://dx.doi.org/10.1016/S0002-9270(99)00765-0

McColl KEL; Gillen D; El-Omar E, 2000, 'The role of gastrin in ulcer pathogenesis', Bailliere S Best Practice and Research in Clinical Gastroenterology, 14, pp. 13 - 26, http://dx.doi.org/10.1053/bega.1999.0056

Palli D; Masala G; Russo A; Saieva C; Bazzoli F; Brenner H; Bode G; Boeing H; Parsonnet J; El-Omar E; McColl KEL, 2000, 'When enthusiasm is infectious [1] (multiple letters)', Gastroenterology, 119, pp. 274 - 276, http://dx.doi.org/10.1053/gast.2000.9116

El-Omar EM; Wang CD; McColl KE; Rabkin CS, 2000, 'Interleukin-10 promoter polymorphisms influence risk of chronic H-pylori infection.', GASTROENTEROLOGY, 118, pp. A889 - A889, http://dx.doi.org/10.1016/S0016-5085(00)85694-2

El-Omar EM; Chow WHM; McColl KE; Fraumeni JF; Rabkin CS, 2000, 'Interleukin-1β-enhancing genotypes are associated with increased risk of gastric cancer and its precursors.', GASTROENTEROLOGY, 118, pp. A181 - A181, http://dx.doi.org/10.1016/S0016-5085(00)82800-0

McColl KEL; Murray LS; El-Omar EM, 1999, 'Helicobacter pylori and nonulcer dyspepsia -: Reply', NEW ENGLAND JOURNAL OF MEDICINE, 340, pp. 1509 - 1510

Lieber CS; Puspok A; Oberhubek G; Logan RFA; Logan RPH; Ganz PA; Scott BB; McColl KEL; Murray LS; El-Omar EM; Blum AL; Talley NJ; Stolte M; Friedman LS, 1999, 'Helicobacter pylori and nonulcer dyspepsia [1] (multiple letters)', New England Journal of Medicine, 340, pp. 1508 - 1511, http://dx.doi.org/10.1056/NEJM199905133401912

Smith AD; Gillen D; Cochran KM; El-Omar E; McColl KEL, 1999, 'Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers', American Journal of Gastroenterology, 94, pp. 1209 - 1213, http://dx.doi.org/10.1016/S0002-9270(99)00124-0

Mccoll KEL; Dickson A; El-Nujumi A; El-Omar E; Kelman A, 1999, 'Symptomatic benefit 1-3 years post H-pylori eradication in ulcer patients: Impact of reflux disease', GUT, 44, pp. A120 - A120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079446300478&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McColl KEL; Murray LS; El-Omar EM, 1999, 'Reply', Gastroenterology, 117, pp. 271 - 272, http://dx.doi.org/10.1016/s0016-5085(99)70580-9

McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T, 1998, 'Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia', New England Journal of Medicine, 339, pp. 1869 - 1874, http://dx.doi.org/10.1056/NEJM199812243392601

McColl KEL; Gillen D; El-Omar E; Ardill J, 1998, 'Effect of antral atrophy on gastric function in h. pylori infection: Relevance to progression to pangastritis', Zeitschrift Fur Gastroenterologie, 36, pp. 1090

El-Omar E; Oien K; El-Nujumi A; Wirz A; Gillen D; Williams C; Ardill JES; Fullarton G; McColl KEL, 1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GASTROENTEROLOGY, 114, pp. A590 - A590, http://dx.doi.org/10.1016/S0016-5085(98)82402-5

McColl KEL; Murray LS; El-Omar E; Kelman AW; Dickson A; El-Nujumi A; Wirz A; Knill-Jones R; Penney C; Cochrane K; Danesh B; Gaw N; Wilson F, 1998, 'UK MRC trial of H-pylori eradication therapy for non-ulcer ulcer dyspepsia.', GASTROENTEROLOGY, 114, pp. A222 - A222, http://dx.doi.org/10.1016/S0016-5085(98)80900-1

McColl KEL; El-Omar E; Gillen D; Oien K, 1998, 'H-pylori-associated hypochlorhydria - Reply', GASTROENTEROLOGY, 114, pp. 620 - 621, http://dx.doi.org/10.1016/S0016-5085(98)70559-1

El-Omar E; Oien K; El-Nujumi A; Wirz A; Gillen D; Williams C; Ardill JES; Fullarton G; Mccoll KEL, 1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GUT, 42, pp. A51 - A51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mccoll KEL; Murray LS; El-Omar E; Kelman AW; Dickson A; El-Nujumi A; Wirz A; Knill-Jones R; Penney C; Cochrane K; Danesh B; Gaw N; Wilson F, 1998, 'UK MRC trial of H-pylori eradication therapy for non-ucler dyspepsia', GUT, 42, pp. A3 - A3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McColl KEL; El-Nujumi A; Murray LS; El-Omar EM; Dickson A; Kelman AW; Hilditch TE, 1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', Gut, 42, pp. 618 - 622, http://dx.doi.org/10.1136/gut.42.5.618

Beales ILP; McColl KEL; El-Omar E; Gillen D; Oien K, 1998, 'H. pylori-associated hypochlorhydria [2] (multiple letters)', Gastroenterology, 114, pp. 618 - 620, http://dx.doi.org/10.1016/s0016-5085(98)70558-x

McColl KEL; El-Omar E; Gillen D, 1998, 'Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy', British Medical Bulletin, 54, pp. 121 - 138, http://dx.doi.org/10.1093/oxfordjournals.bmb.a011663

Back to profile page